Skip to main content
NCBI home page
Brain Pathology logoLink to Brain Pathology
. 2006 Apr 5;13(4):507–518. doi: 10.1111/j.1750-3639.2003.tb00481.x

Genetic Alterations and Aberrant Expression of Genes Related to the Phosphatidyl‐lnositol‐3′‐Kinase/Protein Kinase B (Akt) Signal Transduction Pathway in Glioblastomas

Christiane B Knobbe 1, Guido Reifenberger 1,✉
PMCID: PMC8095764  PMID: 14655756

Abstract

Glioblastomas frequently carry mutations in the PTEN tumor suppressor gene on 10q23.3. The tumor suppressor properties of Pten are closely related to its inhibitory effect on the phosphatidyl‐inositol‐3’‐kinase (Pi3k)‐dependent activation of protein kinase B (Akt) signalling. Here, we report on the analysis of 17 genes related to the Pi3k/Akt signalling pathway for genetic alteration and aberrant expression in a series of 103 glioblastomas. Mutation, homozygous deletion or loss of expression of PTEN was detected in 32% of the tumors. In contrast, we did not find any aberrations in the inositol polyphosphate phosphatase like‐1 gene (INPPL1), whose gene product may also counteract Pi3k‐dependent Akt activation. Analysis of genes encoding proteins that may activate the pathway upstream of Pi3k revealed variable fractions of tumors with EGFR amplification (31%), PDGFRA amplification (8%), and IRS2 amplification (2%). The protein tyrosine kinase 2 (PTK2/FAK1) gene was neither amplified nor over‐expressed at the mRNA level. Investigation of three genes encoding catalytic subunits of Pi3k (PIK3CA, PIK3CD, and PIK3C2B) revealed amplification of PIK3C2B (1q32) in 6 tumors (6%). Overexpression of PIK3C2B mRNA was detected in 4 of these cases. PIK3CD (1p36.2) and PIK3CA (3q26.3) were not amplified but PIK3CD mRNA was overexpressed in 6 tumors (6%). Amplification and overexpression of AKT1 was detected in a single case of gliosarcoma. The IRS1, PIK3R1, PIK3R2, AKT2, AKT3, FRAP1, and RPS6KB1 genes were neither amplified nor overexpressed in any of the tumors. Taken together, our data indicate that different genes related to the Pi3k/Akt signalling pathway may be aberrant in glioblastomas.

Full Text

The Full Text of this article is available as a PDF (378.1 KB).

References

  • 1. Abbi S, Guan JL (2002) Focal adhesion kinase: protein interactions and cellular functions. Histol Histopathol 17: 1163–1171. [DOI] [PubMed] [Google Scholar]
  • 2. Actor B, Cobbers JM, Buschges R, Wolter M, Knobbe CB, Reifenberger G, Weber RG (2002) Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components. Genes Chromosomes Cancer 34: 416–427. [DOI] [PubMed] [Google Scholar]
  • 3. Aoki M, Batista O, Bellacosa A, Tsichlis P, Vogt PK (1998) The akt kinase: molecular determinants of oncogenicity. Proc Natl Acad Sci U S A 95: 14950–14955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Bellacosa A, De Feo D, Godwin AK, Bell DW, Cheng JQ, Altomare DA, Wan M, Dubeau L, Scambia G, Masciullo V (1995) Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. Int J Cancer 64: 280–285. [DOI] [PubMed] [Google Scholar]
  • 5. Bergmann U, Funatomi H, Kornmann M, Beger HG, Korc M (1996) Increased expression of insulin receptor substrate‐1 in human pancreatic cancer. Biochem Biophys Res Commun 220: 886–890. [DOI] [PubMed] [Google Scholar]
  • 6. Besson A, Yong VW (2001) Mitogenic signalling and the relationship to cell cycle regulation in astrocytomas. J Neurooncol 51: 245–264. [DOI] [PubMed] [Google Scholar]
  • 7. Boström J, Cobbers JM, Wolter M, Tabatabai G, Weber RG, Lichter P, Collins VP, Reifenberger G (1998) Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q. Cancer Res 58: 29–33. [PubMed] [Google Scholar]
  • 8. Burgaya F, Toutant M, Studler JM, Costa A, Le Bert M, Gelman M, Girault JA (1997) Alternatively spliced focal adhesion kinase in rat brain with increased autophosphorylation activity. J Biol Chem 272: 28720–28725. [DOI] [PubMed] [Google Scholar]
  • 9. Byun DS, Cho K, Ryu BK, Lee MG, Park JI, Chae KS, Kim HJ, Chi SG (2003) Frequent monoallelic deletion of PTEN and its reciprocal associatioin with PIK3CA amplification in gastric carcinoma. Int J Cancer 104: 318–327. [DOI] [PubMed] [Google Scholar]
  • 10. Cai DX, James CD, Scheithauer BW, Couch FJ, Perry A (2001) PS6K amplification characterizes a small subset of anaplastic meningiomas. Am J Clin Pathol 115: 213–218. [DOI] [PubMed] [Google Scholar]
  • 11. Cantley LC (2002) The phosphoinositide 3‐kinase pathway. Science 296: 1655–1657. [DOI] [PubMed] [Google Scholar]
  • 12. Cavenee WK, Furnari FB, Nagane M, Huang H‐JS, Newcomb EW, Bigner DD, Weller M, Berens ME, Plate KH, Israel MA, Noble MD, Kleihues P (2000). Diffusely infiltrating astrocytomas. In: Pathology and genetics of tumors of the nervous system. WHO classification of tumors. Kleihues P and Cavenee WK (eds). Lyon , France : IARC Press. pp. 10–21. [Google Scholar]
  • 13. Chang Q, Li Y, White MF, Fletcher JA, Xiao S (2002) Constitutive activation of insulin receptor substrate 1 is a frequent event in human tumors: therapeutic implications. Cancer Res 62: 6035–6038. [PubMed] [Google Scholar]
  • 14. Cheng JQ, Godwin AK, Bellacosa A, Taguchi T, Franke TF, Hamilton TC, Tsichlis PN, Testa JR (1992) AKT2, a putative oncogene encoding a member of a subfamily of protein‐serine/threonine kinases, is amplified in human ovarian carcinomas. Proc Natl Acad Sci U S A 89: 9267–9271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Choe G, Horvath S, Cloughesy TF, Crosby K, Seligson D, Palotie A, Inge L, Smith BL, Sawyers CL, Mischel PS (2003) Analysis of the phospatidylinositol 3′‐kinase signalling pathway in glioblastoma patients in vivo. Cancer Res 63: 2742–2746. [PubMed] [Google Scholar]
  • 16. Collins VP (2002) Cellular mechanisms targeted during astrocytoma progression. Cancer Lett1 88: 1–7. [DOI] [PubMed] [Google Scholar]
  • 17. Couch FJ, Wang XY, Wu GJ, Qian J, Jenkins RB, James CD (1999) Localization of PS6K to chromosomal region 17q23 and determination of its amplification in breast cancer. Cancer Res 59: 1408–1411. [PubMed] [Google Scholar]
  • 18. D'Ambrosio C, Keller SR, Morrione A, Lienhard GE, Baserga R, Surmacz E (1995) Transforming potential of the insulin receptor substrate 1. Cell Growth Differ 6: 557–562. [PubMed] [Google Scholar]
  • 19. Fleming TP, Saxena A, Clark WC, Robertson JT, Oldfield EH, Aaronson SA, Ali IU (1992) Amplification and/or overexpression of platelet‐derived growth factor receptors and epidermal growth factor receptor in human glial tumors. Cancer Res 52: 4550–4553. [PubMed] [Google Scholar]
  • 20. Fujioka T, Kim JH, Adachi H, Saito K, Tsujimoto M, Yokoyama S, Ui M (2001) Further evidence for the involvement of insulin receptor substrates in epidermal growth factor‐induced activation of phosphatidylinositol 3‐kinase. Eur J Biochem 268: 4158–4168. [DOI] [PubMed] [Google Scholar]
  • 21. Hecker TP, Grammer JR, Gillespie GY, Stewart J Jr, Gladson CL (2002) Focal adhesion kinase enhances signalling through the Shc/extracellular signal‐regulated kinase pathway in anaplastic astrocytoma tumor biopsy samples. Cancer Res 62: 2699–2707. [PubMed] [Google Scholar]
  • 22. Holland EC, Celestino J, Dai C, Schaefer L, Sawaya RE, Fuller GN (2000) Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat Genet 25: 55–57. [DOI] [PubMed] [Google Scholar]
  • 23. Hui AB, Lo KW, Yin XL, Poon WS, Ng HK (2001) Detection of multiple gene amplifications in glioblastoma multiforme using array‐based comparative genomic hybridization. Lab Invest 81: 717–723. [DOI] [PubMed] [Google Scholar]
  • 24. Ichimura K, Schmidt EE, Goike HM, Collins VP (1996) Human glioblastomas with no alterations of the CDKN2A (p16INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene. Oncogene 13: 1065–1072. [PubMed] [Google Scholar]
  • 25. Jones G, Machado J Jr, Tolnay M, Merlo A (2001) PTEN‐independent induction of caspase‐mediated cell death and reduced invasion by the focal adhesion targeting domain (FAT) in human astrocytic brain tumors which highly express focal adhesion kinase (FAK). Cancer Res 61: 5688–5691. [PubMed] [Google Scholar]
  • 26. Kandel ES, Hay N (1999) The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp Cell Res 253: 210–229. [DOI] [PubMed] [Google Scholar]
  • 27. Kleihues P, Burger PC, Collins VP, Newcomb EW, Ohgaki H, Cavenee WK (2000) Glioblastoma In: Pathology and genetics of tumors of the nervous system. WHO classification of tumors. Kleihues P, Cavenee WK (eds). Lyon , France : IARC Press. pp. 29–39. [Google Scholar]
  • 28. Knobbe CB, Merlo A, Reifenberger G (2002) Pten signalling in gliomas. Neuro-oncol 4: 196–211. [PMC free article] [PubMed] [Google Scholar]
  • 29. Kornmann M, Maruyama H, Bergmann U, Tangvoranuntakul P, Beger HG, White MF, Korc M (1998) Enhanced expression of the insulin receptor substrate‐2 docking protein in human pancreatic cancer. Cancer Res 58: 4250–4254. [PubMed] [Google Scholar]
  • 30. Koschny R, Koschny T, Froster UG, Krupp W, Zuber MA (2002) Comparative genomic hybridization in glioma: a meta‐analysis of 509 cases. Cancer Genet Cytogenet 135: 147–159. [DOI] [PubMed] [Google Scholar]
  • 31. Krystal G, Damen JE, Helgason CD, Huber M, Hughes MR, Kalesnikoff J, Lam V, Rosten P, Ware MD, Yew S, Humphries RK (1999) SHIPs ahoy. Int J Biochem Cell Biol 31: 1007–1010. [DOI] [PubMed] [Google Scholar]
  • 32. Kwabi‐Addo B, Giri D, Schmidt K, Podsypanina K, Parsons R, Greenberg N, Ittmann M (2001) Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression. Proc Natl Acad Sci U S A 98: 11563–11568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R (1997) PTEN, a putative tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943–1947. [DOI] [PubMed] [Google Scholar]
  • 34. Liu W, James CD, Frederick L, Alderete BE, Jenkins RB (1997) PTEN/MMAC1 mutations and EGFR amplification in glioblastomas. Cancer Res 57: 5254–5257. [PubMed] [Google Scholar]
  • 35. Ma YY, Wei SJ, Lin YC, Lung JC, Chang TC, Whang‐Peng J, Liu JM, Yang DM, Yang WK, and Shen CY (2000) PIK3CA as an oncogene in cervical cancer. Oncogene 19: 2739–2744. [DOI] [PubMed] [Google Scholar]
  • 36. Maehama T, Dixon JE (1998) The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5‐trisphosphate. J Biol Chem 273: 13375–13378. [DOI] [PubMed] [Google Scholar]
  • 37. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK, DePinho RA (2001) Malignant glioma: genetics and biology of a grave matter. Genes Dev 15: 1311–1333. [DOI] [PubMed] [Google Scholar]
  • 38. Myers MG Jr, White MF (1996) Insulin signal transduction and the IRS proteins. Annu Rev Pharmacol Toxicol 36: 615–658. [DOI] [PubMed] [Google Scholar]
  • 39. Neshat MS, Mellinghoff IK, Tran C, Stiles B, Thomas G, Petersen R, Frost P, Gibbons JJ, Wu H, Sawyers CL (2001) Enhanced sensitivity of PTEN‐deficient tumors to inhibition of FRAP/mTOR. Proc Natl Acad Sci U S A 98: 10314–10319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Nicholson KM, Anderson NG (2002) The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal 14: 381–395. [DOI] [PubMed] [Google Scholar]
  • 41. Ohgaki H, Biernat W, Reis R, Hegi M, Kleihues P (2000) Gliosarcoma In: Pathology and genetics of tumors of the nervous system. WHO classification of tumors. Kleihues P, Cavenee WK (eds). Lyon , France : IARC Press. pp. 42–44. [Google Scholar]
  • 42. Ohgaki H, Peraud A, Nakazato Y, Watanabe K, von Deimling A (2000) Giant cell glioblastoma In: Pathology and genetics of tumors of the nervous system. WHO classification of tumors. Kleihues P, Cavenee WK (eds). Lyon , France : IARC Press. pp. 40–41. [Google Scholar]
  • 43. Parsons JT, Martin KH, Slack JK, Taylor JM, Weed SA (2000) Focal adhesion kinase: a regulator of focal adhesion dynamics and cell movement. Oncogene 19: 5606–5613. [DOI] [PubMed] [Google Scholar]
  • 44. Podsypanina K, Lee RT, Politis C, Hennessy I, Crane A, Puc J, Neshat M, Wang H, Yang L, Gibbons J, Frost P, Dreisbach V, Blenis J, Gaciong Z, Fisher P, Sawyers C, Hedrick‐Ellenson L, Parsons R (2001) An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in PTEN mice. Proc Natl Acad Sci U S A 98: 10320–10325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Reifenberger J, Wolter M, Bostrom J, Buschges R, Schulte KW, Megahed M, Ruzicka T, Reifenberger G (2000) Allelic losses on chromosome arm 10q and mutation of the PTEN (MMAC1) tumour suppressor gene in primary and metastatic malignant melanomas. Virchows Arch 436: 487–493. [DOI] [PubMed] [Google Scholar]
  • 46. Riemenschneider MJ, Buschges R, Wolter M, Reifenberger J, Bostrom J, Kraus JA, Schlegel U, Reifenberger G (1999) Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification. Cancer Res 59: 6091–6096. [PubMed] [Google Scholar]
  • 47. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual. 2nd edition. USA : Cold Spring Harbor Laboratory Press, pp 9. 17–9. 19. [Google Scholar]
  • 48. Schmelzle T, Hall MN (2000) TOR, a central controller of cell growth. Cell 103: 253–262. [DOI] [PubMed] [Google Scholar]
  • 49. Schmidt EE, Ichimura K, Goike HM, Moshref A, Liu L, Collins VP (1999) Mutational profile of the PTEN gene in primary human astrocytic tumors and cultivated xenografts. J Neuropathol Exp Neurol 58: 1170–1183. [DOI] [PubMed] [Google Scholar]
  • 50. Schnarr B, Strunz K, Ohsam J, Benner A, Wacker J, Mayer D (2000) Down‐regulation of insulin‐like growth factor‐I receptor and insulin receptor substrate‐1 expression in advanced human breast cancer. Int J Cancer 89: 506–513. [DOI] [PubMed] [Google Scholar]
  • 51. Shayesteh L, Lu Y, Kuo WL, Baldocchi R, Godfrey T, Collins C, Pinkel D, Powell B, Mills GB, Gray JW (1999) PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet 21: 99–102. [DOI] [PubMed] [Google Scholar]
  • 52. Smith JS, Wang XY, Qian J, Hosek SM, Scheithauer BW, Jenkins RB, James CD (2000) Amplification of the platelet‐derived growth factor receptor‐A (PDGFRA) gene occurs in oligodendrogliomas with grade IV anaplastic features. J Neuropathol Exp Neurol 59: 495–503. [DOI] [PubMed] [Google Scholar]
  • 53. Sonoda Y, Ozawa T, Aldape KD, Deen DF, Berger MS, Pieper RO (2001) Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma. Cancer Res 61: 6674–6678. [PubMed] [Google Scholar]
  • 54. Staal SP (1987) Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma. Proc Natl Acad Sci U S A 84: 5034–5037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP, Mak TW (1998) Negative regulation of PKB/Akt‐dependent cell survival by the tumor suppressor PTEN. Cell 95: 29–39. [DOI] [PubMed] [Google Scholar]
  • 56. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH, Tavtigian SV (1997) Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15: 356–362. [DOI] [PubMed] [Google Scholar]
  • 57. Tamura M, Gu J, Matsumoto K, Aota S, Parsons R, Yamada KM (1998) Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280: 1614–1617. [DOI] [PubMed] [Google Scholar]
  • 58. Taylor V, Wong M, Brandts C, Reilly L, Dean NM, Cowsert LM, Moodie S, Stokoe D (2000) 5′ phospholipid phosphatase SHIP‐2 causes protein kinase B inactivation and cell cycle arrest in glioblastoma cells. Mol Cell Biol 20: 6860–6871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59. Testa JR, Bellacosa A (2001) AKT plays a central role in tumorigenesis. Proc Natl Acad Sci U S A 98: 10983–10985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Vivanco I, Sawyers CL (2002) The phosphatidylinositol 3‐Kinase/AKT pathway in human cancer. Nat Rev Cancer 2: 489–501. [DOI] [PubMed] [Google Scholar]
  • 61. Wang D, Grammer JR, Cobbs CS, Stewart JE Jr, Liu Z, Rhoden R, Hecker TP, Ding Q, Gladson CL (2000) p125 focal adhesion kinase promotes malignant astrocytoma cell proliferation in vivo. J Cell Sci 113 Pt 23: 4221–4230. [DOI] [PubMed] [Google Scholar]
  • 62. Weber RG, Sabel M, Reifenberger J, Sommer C, Oberstrass J, Reifenberger G, Kiessling M, Cremer T (1996) Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization. Oncogene 13: 983–994. [PubMed] [Google Scholar]
  • 63. Zhou XP, Li YJ, Hoang‐Xuan K, Laurent‐Puig P, Mokhtari K, Longy M, Sanson M, Delattre JY, Thomas G, Hamelin R (1999) Mutational analysis of the PTEN gene in gliomas: molecular and pathological correlations. Int J Cancer 84: 150–154. [DOI] [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES